Reducing anthracycline-induced cardiotoxicity through pharmacogenetics

Erika Scott^{1

2}, Jafar S Hasbullah^{1

2}, Colin Jd Ross^{1

2

3}, Bruce C Carleton^{1

2

4}

Affiliations

¹ Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
² British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
³ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
⁴ Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Editorial

Erika Scott et al. Pharmacogenomics. 2018 Oct.

. 2018 Oct;19(15):1147-1150.

doi: 10.2217/pgs-2018-0124. Epub 2018 Sep 14.

Erika Scott^{1

2}, Jafar S Hasbullah^{1

2}, Colin Jd Ross^{1

2

3}, Bruce C Carleton^{1

2

4}

¹ Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
² British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
³ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
⁴ Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

No abstract available

Keywords: adverse drug reactions; anthracycline-induced cardiotoxicity; pharmacogenomics.

Publication types